|
|
 Previous Article | Table of Contents | Next Article 
Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant
cells expressing the T-cell receptor gamma delta
JP Farcet, P Gaulard, JP Marolleau, JP Le Couedic, T Henni, MF Gourdin, M Divine, C Haioun, S Zafrani and M Goossens
INSERM U91, Departement d'Enseignement, Hopital Henri Mondor, Creteil,
France.
Peripheral T-cell lymphomas consist of a clinically heterogeneous group of
malignant disorders whose immunophenotype usually corresponds to that of
normal mature T cells. We describe and correlate the clinical,
histopathologic, phenotypic, and genotypic findings in two patients with
malignant lymphoma presenting with hepatosplenic disease. The morphologic
pattern of lymphoma was that of a sinusal/sinusoidal infiltration in
spleen, marrow, and liver. This morphologic characteristic was associated
with the presence of a productive clonal rearrangement of the T-cell
receptor (TCR) delta gene. Lymphoma cells expressed a CD3-TCR-gamma delta-
phenotype. They were also double negative (ie, CD4-CD8-) and lacked the CD5
and CD7 antigens. In one patient, tumor progression was associated with
phenotypic changes that resulted in a CD3-TCR-gamma delta- phenotype with
the same delta-gene rearrangement as initially. These observations suggest
the existence of a new type of peripheral T-cell lymphoma characterized by
its hepatosplenic presentation, and by the sinusal/sinusoidal tropism and
the TCR-gamma delta phenotype of the malignant cells.
Volume 75,
Issue 11,
pp. 2213-2219,
06/01/1990
Copyright © 1990 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. S. Braza, A. Caraux, T. Rousset, S. Lafaye de Micheaux, H. Sicard, P. Squiban, V. Costes, B. Klein, and J.-F. Rossi
{gamma}{delta} T Lymphocytes Count Is Normal and Expandable in Peripheral Blood of Patients with Follicular Lymphoma, Whereas It Is Decreased in Tumor Lymph Nodes Compared with Inflammatory Lymph Nodes
J. Immunol.,
January 1, 2010;
184(1):
134 - 140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. S. Falchook, F. Vega, N. H. Dang, F. Samaniego, M. A. Rodriguez, R. E. Champlin, C. Hosing, S. Verstovsek, and B. Pro
Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment
Ann. Onc.,
June 1, 2009;
20(6):
1080 - 1085.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Miyazaki, M. Yamaguchi, H. Imai, T. Kobayashi, S. Tamaru, K. Nishii, M. Yuda, H. Shiku, and N. Katayama
Gene expression profiling of peripheral T-cell lymphoma including {gamma}{delta} T-cell lymphoma
Blood,
January 29, 2009;
113(5):
1071 - 1074.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Jaeger, F. Bauer, R. Brezinschek, C. Beham-Schmid, C. Mannhalter, and P. Neumeister
Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine
Ann. Onc.,
May 1, 2008;
19(5):
1025 - 1026.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Rizvi, A. M. Evens, M. S. Tallman, B. P. Nelson, and S. T. Rosen
T-cell non-Hodgkin lymphoma
Blood,
February 15, 2006;
107(4):
1255 - 1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. Jaffe
Pathobiology of Peripheral T-cell Lymphomas
Hematology,
January 1, 2006;
2006(1):
317 - 322.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Aldinucci, D. Poletto, D. Lorenzon, P. Nanni, M. Degan, K. Olivo, B. Rapana, A. Pinto, and V. Gattei
CD26 Expression Correlates with a Reduced Sensitivity to 2'-Deoxycoformycin-Induced Growth Inhibition and Apoptosis in T-Cell Leukemia/Lymphomas
Clin. Cancer Res.,
January 15, 2004;
10(2):
508 - 520.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Belhadj, F. Reyes, J.-P. Farcet, H. Tilly, C. Bastard, R. Angonin, E. Deconinck, F. Charlotte, V. Leblond, E. Labouyrie, et al.
Hepatosplenic {gamma}{delta} T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients
Blood,
December 15, 2003;
102(13):
4261 - 4269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Fry, W. Vernau, P. A. Pesavento, C. Bromel, and P. F. Moore
Hepatosplenic Lymphoma in a Dog
Veterinary Pathology,
September 1, 2003;
40(5):
556 - 562.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y Sadahira, K Notohara, and T Manabe
Hepatosplenic T cell lymphoma with no expression of cytotoxic molecules
J. Clin. Pathol.,
August 1, 2003;
56(8):
631 - 633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Saito, Y. Matsuno, R. Tanosaki, T. Watanabe, Y. Kobayashi, and K. Tobinai
{gamma}{delta} T-cell neoplasms: a clinicopathological study of 11 cases
Ann. Onc.,
November 1, 2002;
13(11):
1792 - 1798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.S. Chim, C.C.K. Lam, J.M. Nicholls, G.C. Ooi, and Y.L. Kwong
Unusual Hematologic Malignancies: Case 3. CNS Involvement in CD56-Positive Intestinal Gamma/Delta T-Cell Lymphoma
J. Clin. Oncol.,
September 1, 2002;
20(17):
3742 - 3744.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Roccabianca, S. Paltrinieri, E. Gallo, and A. Giuliani
Hepatosplenic T-cell Lymphoma in a Mare
Veterinary Pathology,
July 1, 2002;
39(4):
508 - 511.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Greer, M. C. Kinney, and T. P. Loughran Jr.
T Cell and NK Cell Lymphoproliferative Disorders
Hematology,
January 1, 2001;
2001(1):
259 - 281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. K. Przybylski, H. Wu, W. R. Macon, J. Finan, D. G. B. Leonard, R. E. Felgar, J. A. DiGiuseppe, P. C. Nowell, S. H. Swerdlow, M. E. Kadin, et al.
Hepatosplenic and Subcutaneous Panniculitis-Like {gamma}/{delta} T Cell Lymphomas Are Derived from Different V{delta} Subsets of {gamma}/{delta} T Lymphocytes
J. Mol. Diagn.,
February 1, 2000;
2(1):
11 - 19.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
B. Arnulf, C. Copie-Bergman, M.-H. Delfau-Larue, A. Lavergne-Slove, J. Bosq, J. Wechsler, M. Wassef, C. Matuchansky, B. Epardeau, M. Stern, et al.
Nonhepatosplenic gamma delta T-Cell Lymphoma: A Subset of Cytotoxic Lymphomas With Mucosal or Skin Localization
Blood,
March 1, 1998;
91(5):
1723 - 1731.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Suzuki, K. Yamamoto, M. Seto, Y. Kagami, M. Ogura, Y. Yatabe, T. Suchi, Y. Kodera, Y. Morishima, T. Takahashi, et al.
CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Acute Leukemia: A Distinct Hematolymphoid Disease Entity
Blood,
September 15, 1997;
90(6):
2417 - 2428.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
The Non-Hodgkin's Lymphoma Classification Project
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma
Blood,
June 1, 1997;
89(11):
3909 - 3918.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Smith, C. P. Stowell, and N. L. Harris
Case 42-1993- Jaundice and Anemia Two Weeks after an Aortic Valvuloplasty in a 62-Year-Old Woman with Splenomegaly
N. Engl. J. Med.,
October 21, 1993;
329(17):
1254 - 1261.
[Full Text]
|
|
|
|
|
